Research Article
A Typical Immune T/B Subset Profile Characterizes Bicuspid Aortic Valve: In an Old Status?
Table 1
Demographic and clinical characteristics, comorbidity conditions, and complications of 25 BAV and 35 TAV subjects with or without TAA.
| Variables | BAV | TAV | | |
| Demographic characteristics | | | Age, mean (SD) | 56.7 (13.5) | 66.4 (7.1) | Male sex, number (%) | 19 (76) | 23 (66) | Female sex, number (%) | 6 (24) | 12 (34) | Body mass index, mean (SD) | 26 (4.8) | 26.3 (3.2) | Size and location of TAA | | | Subjects affected (%) | 12 (48) | 17 (48) | Size (mm), mean (SD) | 53.3 (7.4) | 50.3 (6.9) | Location, number (%): | | | Tubular ascending aorta | 12 (100) | 17 (100) | Comorbidity conditions, number (%) | | | CVD family history | 7 (28) | 5 (7.1) | Smoking | 6 (24) | 7 (20) | Hypertension | 18 (72) | 25 (71) | Dyslipidemia | 3 (12) | 5 (14) | Diabetes mellitus | 0 (0) | 0 (0) | Renal failure | 0 (0) | 1 (2) | Dissection | 0 (0) | 0 (0) | Aortic valve pathology, number (%) | | | Normal | 0 (0) | 27 (77) | Prolapse | 3 (12) | 1 (2) | Vascular calcium fibrosis | 7 (28) | 7 (20) | Atherosclerosis coronary syndrome, number (%) | 0 (0) | 0 (0) |
|
|